Atara Biotherapeutics director Brian Cherry acquires 104,166 common shares for $999,993.60

• Atara Biotherapeutics director Brian N. Cherry bought 104,166 common shares in a $9.6 per-share purchase.
• His direct stake increased to 166,486 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000905148-26-004085), on September 04, 2026, and is solely responsible for the information contained therein.